Dr. Martin Zenni II, MD

Dr. Zenni practices at University of Florida Jacksonville Physicians, Inc. in Saint Marys, Georgia.

Dr. Zenni's NPI, 1588631196, was assigned on March 2, 2006. Dr. Zenni graduated from Pritzker School of Medicine in 1986. Dr. Zenni holds Florida license ME68936.

Dr. Zenni's primary practice is University of Florida Jacksonville Physicians, Inc., at 201 Lake Shore Pt, Saint Marys, GA 31558 in Camden County. The practice phone is (904) 244-3500.

Dr. Zenni's primary practice is University of Florida Jacksonville Physicians, Inc. in Saint Marys, Georgia. Dr. Zenni is also affiliated with Southeast Georgia Health System-Camden Campus. The medical group on file is UF Jacksonville Physicians, Inc. Dmand AI also links Dr. Zenni to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zenni practices, 2 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Zenni's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Zenni is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Zenni's licenses on file in 4 states: Florida, Georgia, California and Pennsylvania.

Dmand AI lists angioplasty, cardiac catheterization and pacemaker or defibrillator implantation among the conditions Dr. Zenni treats.

CMS data shows 1,634 Medicare services from Dr. Zenni across 19 procedure codes in 2024, for 838 Medicare patients. Medicare paid $94,415 for them.

CMS counts 838 Medicare patients who saw Dr. Zenni in 2024. The largest group is 65 to 74, with 389 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Zenni's median patient age at 74, with 49% women.

In 2024, Dr. Zenni wrote 1,745 Medicare Part D claims for 316 patients. 92% of them were for generic drugs. CMS names the drug for 1,569 of them, across 28 drugs with 11 or more claims each, at $105,320 in total drug cost. In 2023, CMS named 1,315 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Zenni for performance year 2024, reported individually. Dr. Zenni accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 44 procedures of coronary angioplasty and stenting by Dr. Zenni, more than 80% of the clinicians it reports for that procedure.

Dmand AI links 37 papers to Dr. Zenni, published from 2005 to 2023. 2016 was the busiest year, with 5. The most frequent topics are Platelet Aggregation Inhibitors, Blood Platelets and Clopidogrel. Dr. Zenni has published most often in JACC Cardiovasc Interv. Dr. Zenni's most frequent co-authors are Dominick Joseph Angiolillo, MD, Theodore A. Bass, MD and Fabiana Rollini, MD.

CMS Open Payments shows 11 general payments to Dr. Zenni from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. ShockWave Medical, Inc paid the most, $182.

Dmand AI lists 2 awards for Dr. Zenni.

Dr. Zenni graduated from Pritzker School of Medicine in 1986. Dr. Zenni is a member of ACC.

Dr. Zenni is in network with 17 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.